Drug Trial Radar · NCT03451851
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
120
Actual
Start
Jul 11, 2018
Primary completion
Jul 19, 2023
Study completion Dec 18, 2026
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Mar 2, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of guselkumab in pediatric participants aged greater than or equal to 6 through less than 18 years with chronic plaque psoriasis.
Conditions
- Psoriasis
Interventions
GuselkumabDrug
Participants will receive a weight-based dose of guselkumab subcutaneously.
Placebo for guselkumabDrug
Participants will receive a weight-based dose of placebo for guselkumab subcutaneously.
EtanerceptDrug
Participants will receive a weight-based dose of etanercept (up to 50 mg) subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Percentage of Participants Who Achieved an Investigator's Global Assessment (IGA) Score of Cleared (0) or Minimal (1) at Week 16Time frame: At Week 16
- Part 1: Percentage of Participants Who Achieved Psoriasis Area and Severity Index (PASI) 75 Response at Week 16Time frame: At Week 16
Locations
39 sites in 9 countries. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
University of California, San Diego
San Diego, California
Dermatologic Surgery Specialists
Macon, Georgia
Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's Hospital
Chicago, Illinois
Arlington Dermatology
Rolling Meadows, Illinois
Windsor Dermatology
East Windsor, New Jersey
Mt. Sinai School of Medicine
New York, New York
Wright State Physicians Health Center
Dayton, Ohio
Arlington Center for Dermatology
Arlington, Texas
Dell Children's Medical Center of Central Texas
Austin, Texas
Eastern Health Research
Box Hill, Australia
Royal North Shore Hospital
St Leonards, Australia
Veracity Clinical Research
Woolloongabba, Australia
Cliniques Universitaires Saint Luc
Brussels, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman
Liège, Belgium
Kirk Barber Reseach Inc.
Calgary, Alberta, Canada
Dermatology Research Institute Inc
Calgary, Alberta, Canada
Skin Care Centre
Vancouver, British Columbia, Canada
Universitatsklinikum Bonn
Bonn, Germany
Universitatsklinikum Carl Gustav Carcus Dresden
Dresden, Germany
Universitatsklinikum Frankfurt
Frankfurt, Germany
Universitatsklinikum Schleswig Holstein Kiel
Kiel, Germany
Praxis Dr. med. Beate Schwarz - Germany
Langenau, Germany
Company for Medical Study & Service Selters
Selters, Germany
Hautarztpraxis Dr. Leitz & Kollegen
Stuttgart, Germany
Obudai Egeszsegugyi Centrum Kft
Budapest, Hungary
Debreceni Egyetem
Debrecen, Hungary
Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz
Miskolc, Hungary
Szegedi Tudomanyegyetem
Szeged, Hungary
Ospedali Riuniti Di Ancona
Ancona, Italy
Azienda Ospedaliera Policlinico S. Orsola-Malpighi
Bologna, Italy
AOU di Cagliari
Cagliari, Italy
Azienda Ospedaliera di Padova
Padova, Italy
Arcispedale Santa Maria Nuova - IRCCS
Reggio Emilia, Italy
Radboud University Medical Center
Nijmegen, Netherlands
Dermed Centrum Medyczne Sp z o o
Lodz, Poland
Szpital Dzieciecy im. prof. dr. med. Jana Bogdanowicza w Warszawie
Warsaw, Poland
Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu
Wroclaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.